A detailed history of Manufacturers Life Insurance Company, The transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 30,595 shares of JANX stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,595
Previous 24,048 27.22%
Holding current value
$1.54 Million
Previous $1.01 Million 37.93%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$35.29 - $50.26 $231,043 - $329,052
6,547 Added 27.22%
30,595 $1.39 Million
Q2 2024

Aug 14, 2024

BUY
$35.12 - $64.78 $592,263 - $1.09 Million
16,864 Added 234.74%
24,048 $1.01 Million
Q1 2024

May 14, 2024

BUY
$7.93 - $49.75 $56,969 - $357,404
7,184 New
7,184 $270,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.1B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.